TransCode Therapeutics In... (RNAZ)

AI Score

Unlock

0.46

-0.07 (-12.96%)

At close: Apr 03, 2025, 3:59 PM

0.45

-3.57%

After-hours: Apr 03, 2025, 07:59 PM EDT

Dividends

No dividend history available for TransCode Therapeutics Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

RNAZ News

8 months ago · Why Is TransCode Therapeutics (RNAZ) Stock Down 62% Today? - investorplace.com
10 months ago · Q2 2024 EPS Estimates for TransCode Therapeutics, Inc. (NASDAQ:RNAZ) Decreased by Analyst - https://www.defenseworld.net
10 months ago · Why Is TransCode Therapeutics (RNAZ) Stock Down 14% Today? - investorplace.com
1 year ago · TransCode (RNAZ) Down 50% on Issue of New Common Stock - zacks.com
1 year ago · Why Is TransCode Therapeutics (RNAZ) Stock Down 25% Today? - investorplace.com
1 year ago · Why Is TransCode Therapeutics (RNAZ) Stock Down 69% Today? - investorplace.com
1 year ago · Transcode Therapeutic stock whipsaws lower after cut price placing - proactiveinvestors.com
1 year ago · Why Is TransCode Therapeutics (RNAZ) Stock Up 240% Today? - investorplace.com
1 year ago · TransCode Therapeutics stock skyrockets on positive brain cancer trial results - proactiveinvestors.com
1 year ago · Stonegate Healthcare Partners Announces Publishing of a Thematic Report - The RNA Revolution: Unleashing the Therapeutic Potential of RNAi - newsfilecorp.com